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Seborrheic dermatitis is a chronic relapsing erythema-
tous scaly skin disease, which occurs on sebum rich areas 
such as the face, scalp and chest, with an estimated pre-
valence of 1% to 3% in the general population (1, 2). The 
pathogenesis of seborrheic dermatitis is most likely linked 
to Malassezia species, present on the skin of susceptible in-
dividuals, resulting in non-immunogenic irritation, which is 
related to the production of unsaturated fatty acids deposited 
on the skin surface (2). It may also be present in conjunction 
with other skin diseases, e.g., rosacea and acne vulgaris (2). 
Treatment options for seborrheic dermatitis include kera-
tolytic agents, corticosteroids, and antifungal agents (2, 3).
Seborrheic dermatitis has previously been associated 
with psychiatric conditions, such as schizophrenia accom-
panied by tardive dyskinesia, and depression (4, 5). In 
addition, antipsychotics were linked to the onset of sebo-
rrheic dermatitis in psychiatric patients (6-8). However, 
seborrheic dermatitis has not been reported as a side effect 
of any antipsychotic.
The goal of this observational study was to assess the 
prevalence of seborrheic dermatitis in psychiatric inpati-
ents at the acute psychiatric ward.
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Seborrheic dermatitis is a chronic relapsing erythematous scaly skin disease with an estimated prevalence of 1% 
to 3% in the general population. Some studies linked seborrheic dermatitis to neuroleptic induced parkinsonism. We 
conducted a one-month observational study of the incidence of seborrheic dermatitis in 54 psychiatric inpatients treated 
with both typical and atypical antipsychotics. Seven patients manifested seborrheic dermatitis. One patient was hos-
pitalized for the first time and had never been treated with antipsychotics prior to this hospitalization. The majority of 
patients with seborrheic dermatitis were treated with clozapine. Our observational study confirmed a higher prevalence 
of seborrheic dermatitis in psychiatric inpatients. We recommend additional research in dermatological adverse effects 
of antipsychotics, especially seborrheic dermatitis. 
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PATIENTS AND METHODS
During a one-month period, psychiatric inpatients at 
the Acute Male Ward, ugljan Psychiatric Hospital, tre-
ated with both typical and atypical antipsychotics were 
examined for signs of seborrheic dermatitis. The diagnosis 
was confirmed by a dermatologist. Data on patient age, 
psychiatric diagnoses and type of antipsychotic treatment 
were collected from medical documentation. Patients were 
asked to give their informed consent on study participati-
on and the study was approved by the institutional Ethics 
Committee of the ugljan Psychiatric Hospital. Descriptive 
statistics was used on data processing, performed using 
MS excel (Microsoft office Professional edition excel 
2003).
RESULTS
A total of 54 male patients, mean age 47.7 years, were 
included in the study, seven (12.96%) of them manifesting 
seborrheic dermatitis. Six patients were diagnosed with 
paranoid schizophrenia (F20.0) and one was diagnosed 
with schizoaffective disorder (F25.0). The antipsychotics 
used in the treatment of patients manifesting seborrheic 
dermatitis are listed in Table 1.
In addition to antipsychotics, two of seven patients with 
seborrheic dermatitis were treated with biperiden due to 
drug induced extrapyramidal syndrome. Other patients did 
not manifest extrapyramidal syndrome.
DISCUSSION
Seven patients manifested seborrheic dermatitis, acco-
unting for 12.96% of study participants and yielding a 
higher prevalence than reported for the general populati-
on, which is 1%-3% (1, 2). Most patients with seborrheic 
dermatitis were treated with a combination of atypical 
antipsychotics, predominantly clozapine and olanzapine. 
the majority of patients with seborrheic dermatitis were 
treated with clozapine. our observational study confirmed 
a higher prevalence of seborrheic dermatitis in psychiatric 
inpatients. Some studies linked seborrheic dermatitis to 
neuroleptic induced parkinsonism. In a study published in 
1984, 25 of 42 chronic patients with neuroleptic induced 
parkinsonism were found to have seborrheic dermatitis 
(6). Another study from 1983 compared the incidence 
of seborrheic dermatitis between psychiatric patients 
with and without developed parkinsonism and showed a 
statistically significantly higher prevalence of clinically 
diagnosed seborrheic dermatitis in the group with drug 
induced parkinsonism (7). In comparison, two patients 
from our study manifested drug induced extrapyramidal 
syndrome. In 2007, three cases of seborrheic dermatitis 
in patients treated with atypical antipsychotics were re-
ported (8).
The limitations of our study included observational 
design, small number of participants and the fact that all 
participants were male.
We recommend additional research in dermatological 
adverse effects of antipsychotics, especially seborrheic 
dermatitis. 
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Antipsychotic Patient Clozapine Olanzapine Quetiapine Risperidone Haloperidol Levomepromazine
Patient 1 + +
Patient 2 + +
Patient 3 + +
Patient 4 + +
Patient 5 +
Patient 6 + +
Patient 7 + +
Total 4 3 1 3 1 1
Table 1
Antipsychotics in patients manifesting seborrheic dermatitis
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SAŽetAk
SeBoroIČNI DerMAtItIS koD PSIHIJAtrIJSkIH BoLeSNIkA LIJeČeNIH ANtIPSIHotICIMA: 
OPSERVACIJSKA STUDIJA
G. MIJALJICA1,3, D. BrItVIć2,3 i A. SABLJAR1
1Psihijatrijska bolnica Ugljan, Ugljan, 2Klinički bolnički centar Split, Klinika za psihijatriju i 3Sveučilište u Splitu, 
Medicinski fakultet, Split, Hrvatska
Seboroični dermatitis je kronična upalna bolest kože praćena crvenilom i ljuštenjem učestalost koje se procjenjuje 
na 1%-3% u općoj populaciji. Određeni broj objavljenih studija povezuje seboroični dermatitis s parkinsonizmom uzro-
kovanim neurolepticima. Proveli smo opservacijsku studiju incidencije seboroičnog dermatitisa kod 54 hospitalizirana 
bolesnika muškog spola u razdoblju od jednog mjeseca. Bolesnici su liječeni tipičnim i atipičnim antipsihoticima. Kod 
7 bolesnika utvrđen je seboroični dermatitis. Kod jednog bolesnika radilo se o prvoj psihijatrijskoj hospitalizaciji i do 
tada nije liječen antipsihoticima. Većina bolesnika kod kojih je utvrđen seboroični dermatitis liječena je klozapinom. 
Naša opservacijska studija potvrdila je veću učestalost seboroičnog dermatitisa kod hospitaliziranih psihijatrijskih 
bolesnika. Preporučujemo daljnja istraživanja dermatoloških nuspojava antipsihotika uključujući seboroični dermatitis. 
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